We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Dietary Flaxseed Slows Tumor Growth in Mouse Model

By LabMedica International staff writers
Posted on 20 Apr 2009
Results obtained from experiments with mice prone to development of intestinal tumors showed that a diet enriched with flaxseed meal or oil decreased the number and size of tumors as compared to animals whose diets were supplemented with corn meal or oil.

Flaxseed is the richest plant source of lignan precursors, which are important because the lignans that mammals produce from this food precursor have been shown to be protective against breast and colon cancer. More...
Furthermore, flaxseed contains secoisolariciresinol diglucoside (SDG), a potent antioxidant and a known precursor of the mammalian lignans, enterolactone and enterodiol. These compounds have other pharmacological properties including phytoestrogen properties similar to isoflavones.

In the current study investigators at South Dakota State University (Brookings, USA) chose to investigate the possible chemopreventive effects of dietary flaxseed on the development of intestinal tumors in ApcMin mice, a strain that develops spontaneous intestinal tumors due to a mutation.

To this end they separated ApcMin mice into five different groups, which were fed with control (AIN-93M meal), corn meal, flaxseed meal, corn oil, or flaxseed oil supplemented diets.

Results published in the March 2, 2009, issue of the journal Nutrition and Cancer showed that dietary flaxseed significantly decreased the number and size of tumors in the small intestine and colon as compared to control, corn-treated groups. Intestine, colon, and serum samples of corn-treated groups showed higher levels of omega -6 fatty acids, whereas the flaxseed treated groups exhibited higher levels of omega -3 fatty acids. Lignans were detected in the serum, intestine, and colon samples from the flaxseed meal group. Colon samples from the flaxseed meal group showed significantly lower expression of the enzymes COX-1 and COX-2 as compared to similar samples from the corn meal group.

"Results indicated that mice on diets supplemented with flaxseed meal and flaxseed oil had, on average, 45% fewer tumors in the small intestine and the colon compared to the control group," said senior author Dr. Chandradhar Dwivedi, professor of pharmaceutical sciences at South Dakota State University. "Dietary flaxseed oil and meal are effective chemopreventive agents against colon and intestinal tumor development in experimental animal models. Further studies are needed to establish the optimal amount of flaxseed that should be incorporated into human diets to get an antitumor benefit and to explore the possible mechanism of action by which flaxseed can help prevent colon cancer."

Related Links:
South Dakota State University


Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Nasopharyngeal Applicator
CalgiSwab 5.5" Sterile Mini-tip Calcium Alginate Nasopharyngeal Swab w/Aluminum HDLE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.